Middle East Pharmaceutical Industries Company (TADAWUL:4016)
Saudi Arabia
· Delayed Price · Currency is SAR
103.50
+0.60 (0.58%)
Apr 29, 2026, 3:15 PM AST
TADAWUL:4016 Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2,066 | 2,224 | 2,436 | - | - | - | |
| Market Cap Growth | -20.29% | -8.70% | - | - | - | - | |
| Enterprise Value | 2,095 | 2,267 | 2,496 | - | - | - | |
| Last Close Price | 103.30 | 109.71 | 118.00 | - | - | - | |
| PE Ratio | 21.30 | 22.93 | 30.51 | - | - | - | |
| Forward PE | - | 20.16 | 24.86 | - | - | - | |
| PS Ratio | 4.49 | 4.83 | 6.18 | - | - | - | |
| PB Ratio | 4.96 | 5.34 | 6.62 | - | - | - | |
| P/TBV Ratio | 5.84 | 6.29 | 7.67 | - | - | - | |
| P/FCF Ratio | 28.02 | 30.16 | 111.20 | - | - | - | |
| P/OCF Ratio | 23.34 | 25.12 | 73.65 | - | - | - | |
| EV/Sales Ratio | 4.55 | 4.92 | 6.33 | - | - | - | |
| EV/EBITDA Ratio | 17.59 | 19.03 | 25.19 | - | - | - | |
| EV/EBIT Ratio | 19.60 | 21.20 | 27.95 | - | - | - | |
| EV/FCF Ratio | 28.42 | 30.74 | 113.93 | - | - | - | |
| Debt / Equity Ratio | 0.15 | 0.15 | 0.17 | 0.20 | 0.30 | 0.33 | |
| Debt / EBITDA Ratio | 0.54 | 0.54 | 0.64 | 0.73 | 1.11 | 1.05 | |
| Debt / FCF Ratio | 0.87 | 0.87 | 2.89 | 0.86 | 1.44 | 3.44 | |
| Net Debt / Equity Ratio | 0.07 | 0.07 | 0.11 | 0.15 | 0.22 | 0.26 | |
| Net Debt / EBITDA Ratio | 0.25 | 0.25 | 0.41 | 0.55 | 0.80 | 0.82 | |
| Net Debt / FCF Ratio | 0.40 | 0.40 | 1.85 | 0.65 | 1.04 | 2.69 | |
| Asset Turnover | 0.82 | 0.82 | 0.80 | 0.76 | 0.70 | 0.73 | |
| Inventory Turnover | 1.77 | 1.77 | 1.68 | 1.44 | 1.37 | 1.45 | |
| Quick Ratio | 2.24 | 2.24 | 1.85 | 1.49 | 1.36 | 1.59 | |
| Current Ratio | 3.13 | 3.13 | 2.65 | 2.36 | 2.22 | 2.30 | |
| Return on Equity (ROE) | 24.73% | 24.73% | 23.67% | 22.44% | 21.72% | 25.52% | |
| Return on Assets (ROA) | 11.87% | 11.87% | 11.39% | 10.83% | 10.10% | 12.09% | |
| Return on Invested Capital (ROIC) | 23.25% | 23.40% | 21.67% | 20.57% | 18.76% | 22.59% | |
| Return on Capital Employed (ROCE) | 22.90% | 22.90% | 22.70% | 23.40% | 22.30% | 25.40% | |
| Earnings Yield | 4.70% | 4.36% | 3.28% | - | - | - | |
| FCF Yield | 3.57% | 3.32% | 0.90% | - | - | - | |
| Dividend Yield | 2.43% | - | 1.70% | - | - | - | |
| Payout Ratio | 48.43% | 48.43% | 18.79% | 54.69% | 61.14% | 56.12% | |
| Total Shareholder Return | 2.37% | - | 1.70% | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.